NewAmsterdam (NAMS) via Frazier Lifesciences (FLAC) deck

NewAmsterdam Pharma is a late clinical-stage company focused on the research and development of transformative oral therapies for major cardiometabolic diseases.

Debarshi Ghosh

This post is for subscribers only

Subscribe

Already have an account? Log in